Neuromodulation trials

Thoracic Neuromodulation for Diabetic Gastroparesis

RecruitingNCT05273788Phase: PHASE1Started 2022-07-27

Summary

The global incidence of diabetes is rising. Gastroparesis is a significant complication of diabetes that results in debilitating symptoms and affects quality of life. Current treatment options for dia

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
85 Years

Locations

Augusta UniversityAugusta, Georgia, United States

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT05273788